Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT05460000What this trial is testingA Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line TherapyWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more North Eastern German Society of Gynaecological Oncology 640
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT00008138What this trial is testingS0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer SWOG Cancer Research Network 62
Testing effectiveness (Phase 2)Study completedNCT00022347What this trial is testingTLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00005026What this trial is testingCombination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerWho this might be right forOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00003385What this trial is testingCombination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group 48
Testing effectiveness (Phase 2)Study completedNCT02853318What this trial is testingPembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+11 more Roswell Park Cancer Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT00004221What this trial is testingCombination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerWho this might be right forMalignant Ovarian Mixed Epithelial TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+5 more Gynecologic Oncology Group 12
Very early researchStudy completedNCT01504126What this trial is testingPropranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+32 more M.D. Anderson Cancer Center 32
Not applicableUnknownNCT00897039What this trial is testingLaboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Southeastern Gynecologic Oncology 60
Testing effectiveness (Phase 2)Looking for participantsNCT05112601What this trial is testingTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+6 more National Cancer Institute (NCI) 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)Study completedNCT05130515What this trial is testingAnlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.Who this might be right forPlatinum-resistant Recurrent Clear Cell Ovarian Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03355976What this trial is testingBrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell CarcinomasWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+2 more Brown University 46
Early research (Phase 1)Study completedNCT02020707What this trial is testingNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersWho this might be right forCervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more Mayo Clinic 43
Large-scale testing (Phase 3)UnknownNCT00719303What this trial is testingDiet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+30 more Gynecologic Oncology Group 1,070
Testing effectiveness (Phase 2)Study completedNCT03602586What this trial is testingTesting Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian CancerWho this might be right forMalignant Ovarian Clear Cell TumorRecurrent Ovarian Carcinoma National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Looking for participantsNCT07718854What this trial is testingSacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell CancerWho this might be right forOvarian Clear Cell CarcinomaMetastatic Ovarian CancerRecurrent Ovarian Clear Cell Adenocarcinoma Tufts Medical Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02446600What this trial is testingTesting the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Transitional Cell CarcinomaFallopian Tube Undifferentiated Carcinoma+10 more National Cancer Institute (NCI)